Episode 2164
2164: Interview with CEO, Sara Barrington of Verici DX
The Vox Markets Podcast · Vox Markets Podcast
August 6, 202525m 59s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this upbeat interview, CEO Sara Barrington of
Verici DX – a next generation medical diagnostics firm focusing on the global kidney transplant market - takes me through:
00:00 Verici's £6.35m recent fund raise and planned use of proceeds.
02:45 Commercialisation of its flagship blood test Tutivia.
09:20 $300m total addressable market for Tutivia
21:35 Relationship with Thermo Fisher Scientific (re pre-graft Clarava/PTRA test)
24:15 Update on 3rd diagnostic (Protega) and closing remarks
Verici DX – a next generation medical diagnostics firm focusing on the global kidney transplant market - takes me through:
00:00 Verici's £6.35m recent fund raise and planned use of proceeds.
02:45 Commercialisation of its flagship blood test Tutivia.
09:20 $300m total addressable market for Tutivia
21:35 Relationship with Thermo Fisher Scientific (re pre-graft Clarava/PTRA test)
24:15 Update on 3rd diagnostic (Protega) and closing remarks